Literature DB >> 26113400

From unilateral to bilateral parkinsonism: Effects of lateralization on dyskinesias and associated molecular mechanisms.

C Marin1, M Bonastre2, G Mengod3, R Cortés3, M C Rodríguez-Oroz4.   

Abstract

The mechanisms underlying lateralization and progression of motor symptoms from unilateral to bilateral in Parkinson's disease (PD) remain to be elucidated. In addition, the molecular mechanisms involved in levodopa-induced dyskinesias (LIDs) depending on lateralization and disease progression from unilaterally to bilateral have not been described yet. We investigated motor symptoms, LIDs and associated striatal molecular markers expression after unilateral left or right, and after a sequential bilateral 6-hydroxydopamine (6-OHDA)-induced nigrostriatal lesions in rats. Sequentially bilateral lesioned animals showed a bilateral increase in striatal preproenkephalin (PPE) mRNA without changes in pre-prodynorphin (PDyn) mRNA expression. The increase in dyskinesias when parkinsonism becomes bilateral was mostly due to an increase in orolingual dyskinesias associated to a increase in PDyn mRNA expression. Right lesion induces, or facilitates when first-done, a greater level of LIDs and an increase in striatal PPE and PDyn mRNAs in the second lesioned side. We describe a new striatal molecular pattern that appears when parkinsonism becomes bilateral and the relevance of the lateralization for the development of LIDs.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  6-Hydroxydopamine; Basal ganglia; Dyskinesia; Parkinson's disease; Preprodynorphin; Preproenkephalin

Mesh:

Substances:

Year:  2015        PMID: 26113400     DOI: 10.1016/j.neuropharm.2015.06.004

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  4 in total

1.  Hints on the Lateralization of Dopamine Binding to D1 Receptors in Rat Striatum.

Authors:  Rafael Franco; Verònica Casadó-Anguera; Ana Muñoz; Milos Petrovic; Gemma Navarro; Estefanía Moreno; José Luis Lanciego; José Luis Labandeira-García; Antoni Cortés; Vicent Casadó
Journal:  Mol Neurobiol       Date:  2015-10-09       Impact factor: 5.590

2.  Levodopa/Benserazide Loaded Microspheres Alleviate L-dopa Induced Dyskinesia through Preventing the Over-Expression of D1R/Shp-2/ERK1/2 Signaling Pathway in a Rat Model of Parkinson's Disease.

Authors:  Ying Wan; Na Wu; Lu Song; Xijin Wang; Zhenguo Liu; Weien Yuan; Jing Gan
Journal:  Front Aging Neurosci       Date:  2017-10-18       Impact factor: 5.750

3.  Antidyskinetic Treatment with MTEP Affects Multiple Molecular Pathways in the Parkinsonian Striatum.

Authors:  Jing-Ya Lin; Zhen-Guo Liu; Cheng-Long Xie; Lu Song; Ai-Juan Yan
Journal:  Parkinsons Dis       Date:  2017-10-30

Review 4.  The Rodent Models of Dyskinesia and Their Behavioral Assessment.

Authors:  Qiwei Peng; Shaoping Zhong; Yang Tan; WeiQi Zeng; Ji Wang; Chi Cheng; Xiaoman Yang; Yi Wu; Xuebing Cao; Yan Xu
Journal:  Front Neurol       Date:  2019-10-11       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.